Pregled bibliografske jedinice broj: 474637
Analytical validation of therapeutic drug monitoring (TDM) on AxSYM Abbott analyzer
Analytical validation of therapeutic drug monitoring (TDM) on AxSYM Abbott analyzer // Biochemia medica, 20 (2010), 2; 253-259 doi:10.11613/BM.2010.032 (recenziran, članak, stručni)
CROSBI ID: 474637 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Analytical validation of therapeutic drug monitoring (TDM) on AxSYM Abbott analyzer
Autori
Nikolac, Nora ; Šimundić, Ana-Maria ; Vukelić, Nada ; Papić Futač, Dalja ; Vrkić, Nada
Izvornik
Biochemia medica (1330-0962) 20
(2010), 2;
253-259
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
analytical validation; measurement uncertainty; valproic acid; phenobarbital; carbamazepine; theophylline
Sažetak
Careful monitoring of drug concentration (therapeutic drug monitoring, TDM) is essential for a large number of drugs. The aim of this study was to evaluate analytical performance of Abbott AxSYM analyzer for therapeutic drug monitoring of theophylline, carbamazepine, phenobarbital and valproic acid. For the purpose of analytical validation following parameters were determined for all analytes: inaccuracy (bias), within-run and between-run imprecision and measurement uncertainty. Additionally, concentration of valproic acid was compared with the previously used analytical system (TDx FLx Abbott analyzer) for 30 patients’ samples. Inaccuracy results (bias) were as follows: for theophylline from –3.66% to –5.84% ; for carbamazepine –0.46% to 1.00% ; for phenobarbital –1.83% to –8.08% and for valproic acid from – 1.01% to –5.65%. The highest coefficient of variation (CV) for within run imprecision was observed for phenobarbital (7.07%) and the lowest for theophylline (2.71%). The highest CV for between run imprecision was observed for carbamazepine (4.73%) and the lowest for theophylline (2.94%). The highest measurement uncertainty was observed for phenobarbital assay (21.7%) and the lowest for carbamazepine (10.7%). Passing-Bablock regression analysis of valproic acid comparison on two analyzers showed statistically significant, but clinically insignificant deviation in slope of the regression equation (b = 1.121 ; 95% CI = 1.028– 1.197) ; however the Cusum linearity test proved that there was a linear relationship between two methods. In conclusion, analytical validation fulfilled all previously established criteria and could be implemented in a routine laboratory work.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Farmacija
POVEZANOST RADA
Projekti:
134-0061245-0205 - Hemoreološki poremećaji u kroničnim bolestima (Vrkić, Nada, MZOS ) ( CroRIS)
134-1340227-0200 - Upala i udio farmakogenetike u razvoju i ishodu akutnih i kroničnih bolesti (Šimundić, Ana-Maria, MZOS ) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
Uključenost u ostale bibliografske baze podataka::
- CA Search (Chemical Abstracts)
- EMBASE (Excerpta Medica)